Exp Clin Endocrinol Diabetes 2004; 112(6): 333-337
DOI: 10.1055/s-2004-820912
Case Report

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Pregnancy in a Woman Suffering from Type 1 Diabetes Associated with Addison's Disease and Hashimoto's Thyroiditis (Fully Developed Autoimmune Polyglandular Syndrome Type 2)

K. Stechova1 , D. Bartaskova2 , M. Mrstinova3 , M. Cerny4 , M. Snajderova1 , O. Cinek1 , Z. Sumnik1 , J. Vavrinec1
  • 12nd Department of Paediatrics, University Hospital Motol in Prague, Czech Republic
  • 2Department of Internal Medicine, University Hospital Motol in Prague, Czech Republic
  • 3Department of Gynaecology and Obstetrics, University Hospital Motol in Prague, Czech Republic
  • 4Department of Gynaecology and Obstetrics, NICU, University Hospital Motol in Prague, Czech Republic
Weitere Informationen

Publikationsverlauf

Received: June 23, 2003 First decision: August 20, 2003

Accepted: October 6, 2003

Publikationsdatum:
24. Juni 2004 (online)

Abstract

In this article the pregnancy of a woman suffering from the complete triad typical of Autoimmune Polyglandular Syndrome Type 2 (Addison's disease + type 1 diabetes + Hashimoto's thyroiditis) is reported.

By using insulin pump therapy with insulin lispro, it was possible to balance diabetes control with changes of steroid replacement therapy. Pregnancy was uneventful until week 27, when signs of preeclampsia occurred. The boy was born without difficulty at gestational age 37 weeks by planned cesarean section but signs of diabetic fetopathy (macrosomia, hypoglycaemia and hypocalcaemia) were expressed. He required a short course of hydrocortisone therapy. He made a good and rapid recovery. The mother made a good post-operative recovery too, but 4 months after the delivery microalbuminuria as well as mild hyperuricemia are still present.

Interdisciplinary approach and very careful observation of the mother as well as of the child enabled successful outcome of this highly risky pregnancy.

References

  • 1 Albert E, Dalaker K, Jorde R, Berge N. Addison's disease and pregnancy.  Acta Obstet Gynecol Scand. 1989;  68 185-187
  • 2 Betterle C, Volpato M. Adrenal and ovarian autoimmunity.  Eur J Endocrinol. 1998;  138 16-25
  • 3 Betterle C, Dal Pra C, Greggio A, Volpato M, Zanchetta R. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.  Annales d'Endocrinologie. 2001;  62 193-201
  • 4 Cinek O, Koloušková S, Pechová M, Šumník Z, Sedláková P, Bendukidze A, Ivašková E, Šnajderová M, Vavřinec J. Prediction of insulin dependent diabetes mellitus in first-degree relatives of diabetic patients.  Čas Lék čes. 2001;  140 492-496
  • 5 Don-Wauchope A C, Toft A D. Diagnosis and management of Addison's disease.  Practitioner. 2001;  244 794-799
  • 6 Eisenbarth G S. Autoimmune polyendocrine syndromes (Chapter 8). http://www.uchsc.edu/misc/diabetes/oxch8.html . Eisenbarth GS Type 1 Diabetes: Molecular, Cellular, and Clinical Immunology. 2nd ed. 2003
  • 7 Gabbe S G, Holing E, Temple P, Brown Z A. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus.  Am J Obstet Gynecol. 2000;  182 1283-1291
  • 8 Gaither K, Wright R, Apuzzio J J, Gittens L, Ganesh V. Pregnancy complicated by autoimmune polyglandular syndrome type II: A case report.  J Maternal-Fetal Medicine. 1998;  7 154-156
  • 9 Gradden C, Lawrence D, Doyle P M, Welch C R. Uses of error: Addison's disease in pregnancy.  Lancet. 2001;  357 1197
  • 10 Jeffcoate W. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency.  Ann Clin Biochem. 1999;  36 151-157
  • 11 Lenhard M J, Reeves G D. Continuous subcutaneous insulin infusion. A comprehensive review of insulin pump therapy.  Arch Intern Med. 2001;  161 2293-2300
  • 12 Lockshin M D, Sammaritano L R. Corticosteroids during pregnancy.  Scand J Rheumatol Suppl. 1998;  107 136-138
  • 13 Neufeld M, Blizzard R M. Polyglandular autoimmune diseases. Pinchera A, Doniach D, Fenzi GF, Baschieri L Symposium on Autoimmune Aspects of Endocrine Disorders. New York; Academia Press 1980: 357-365
  • 14 Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours.  Tissue Antigens. 1993;  41 119-134
  • 15 Roth B, Kribs A, Kribs M, Solbach G H. Pregnancy in Addison disease and diabetes mellitus.  Z Geburtshilfe Perinatol. 1990;  194 95-97
  • 16 Service F J, Nelson R L. Characteristics of glycemic stability.  Diabetes Care. 1980;  3 58-62
  • 17 Treloar S A, Cooper D W, Brennecke S P, Grehan M M, Martin N G. An Australian twin study of the genetic basis of preeclampsia and eclampsia.  Am J Obstet Gynecol. 2001;  184 374-381
  • 18 Vaidya B, Pearce S, Kendall-Taylor P. Recent advances in the molecular genetics of congenital and aquired primary adrenocortical failure.  Clin Endocrinol. 2000;  53 403-418
  • 19 Vavrinec J, Cinek O, Sumnik Z, Kolouskova S, Malcova H, Drevinek P, Snajderova M. Prediction of type 1 diabetes mellitus in first degree Czech relatives of diabetic patients.  Vnitr Lek. 2002;  48 483-489

M. D., PhD Katerina Stechova

2nd Department of Paediatrics
University Hospital Motol in Prague

V Uvalu 84

Prague 5 - Motol, 15006

Czech Republic

Telefon: + 420224432200

Fax: + 42 02 24 43 22 20

eMail: KaterinaStechova@seznam.cz

    >